Vivo Opportunity Fund Holdings L.P. 13D and 13G filings for Aclaris Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-21 4:51 pm Purchase | 2024-11-19 | 13G | Aclaris Therapeutics, Inc. ACRS | Vivo Opportunity Fund Holdings L.P. | 7,955,160 7.400% | 7,955,160 (New Position) | Filing |